Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis.

ABSTRACT:

SUBMITTER: Ghosh J 

PROVIDER: S-EPMC8668575 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature